The Egyptian Drug Authority has issued a warning to citizens regarding 'Diet Hub' clinics, which have been found selling unregistered weight loss injections of unknown origin. This announcement was made on October 1, 2026, as part of the authority's regulatory and supervisory role in protecting public health. The authority's Central Administration for Pharmaceutical Care discovered this violation through routine monitoring and received reports from concerned individuals.
The specific violation, coded C470/26, involves the publication of an advertisement containing misleading marketing claims for a product called 'Deca Hormone,' which is not registered with the authority. The advertisement was detected on Facebook, owned by 'Diet Hub,' in August 2026, in the form of a video/film promotional material. The authority emphasized that the presence of any product or advertisement on its list of advertising violations reflects its regulatory stance based on verified facts at the time of publication.
The Egyptian Drug Authority stressed that its listing of a product or advertisement as a violation does not constitute a judicial ruling. The authority urged citizens to exercise caution and avoid being swayed by unknown advertisements or untrusted products. It emphasized the importance of consulting official sources to verify the registration of any product before use.
The authority encouraged citizens to report any advertising violations or unregistered products through available channels, including the official website, a dedicated QR code, and a hotline (15301). All reports and information received are handled confidentially and with full protection for the reporters.
The Egyptian Drug Authority plays a crucial role in ensuring the safety and efficacy of pharmaceutical products and services in Egypt. Its regulatory efforts aim to prevent the distribution of substandard or counterfeit products that could harm public health. By monitoring advertisements and product registrations, the authority works to maintain public trust in the healthcare system.
The warning against 'Diet Hub' clinics highlights the ongoing challenges in regulating online advertisements and ensuring compliance with health and safety standards. The authority's proactive measures demonstrate its commitment to protecting citizens from potential health risks associated with unregistered or counterfeit products.
In conclusion, the Egyptian Drug Authority's alert serves as a reminder for citizens to prioritize their health and safety by choosing only registered and verified products and services. By doing so, individuals can contribute to a safer healthcare environment and help prevent the spread of counterfeit or substandard products.
Key points
- The Egyptian Drug Authority warns against 'Diet Hub' clinics selling unregistered weight loss injections of unknown origin.
- The authority discovered the violation through routine monitoring and public reports, and it urges citizens to report similar cases.
- Citizens are advised to verify product registration through official sources before use and to use designated channels for reporting violations.
